Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

BACKGROUND: Tumour relapse is recognized to be the prime fatal burden in patients affected by head and neck squamous cell carcinoma (HNSCC), but no discrete molecular trait has yet been identified to make reliable early predictions of tumour recurrence. Expression of cell surface proteoglycans (PGs)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Farnedi, Anna, Rossi, Silvia, Bertani, Nicoletta, Gulli, Mariolina, Silini, Enrico Maria, Mucignat, Maria Teresa, Poli, Tito, Sesenna, Enrico, Lanfranco, Davide, Montebugnoli, Lucio, Leonardi, Elisa, Marchetti, Claudio, Cocchi, Renato, Ambrosini-Spaltro, Andrea, Foschini, Maria Pia, Perris, Roberto
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4429505/
https://ncbi.nlm.nih.gov/pubmed/25935541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1336-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars